Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]VC005 in Healthy Chinese Males
NCT06974292Phase 1Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- May 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of VC-005 in atopic dermatitis (AD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd. Primary endpoints: Cumulative excretion rate of radioactivity in urine, Cumulative excretion rate of radioactivity in feces and 1 more. Started May 2025; status: completed.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06974292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06974292.